SynthesisJournal of translational medicine2026

A new hope with CAR T-cell therapy for refractory idiopathic inflammatory myopathies: a systematic review.

Xueyan Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.